Correction
Accepted on 12 May 2026
Correction: Budget impact analysis of the introduction of ranibizumab’s biosimilar to the Jordanian joint procurement system
in Health Economics
Correction
Accepted on 12 May 2026
in Health Economics
Systematic Review
Accepted on 12 May 2026
in Genitourinary Oncology
Mini Review
Accepted on 12 May 2026
in Cell Death and Survival
Mini Review
Accepted on 12 May 2026
in Cell Death and Survival
Original Research
Accepted on 12 May 2026
in Pediatric Endocrinology
Case Report
Accepted on 12 May 2026
in Visceral Surgery
Review
Accepted on 12 May 2026
in Animal Nutrition and Metabolism
Original Research
Accepted on 12 May 2026
in Pediatric Oncology
Systematic Review
Accepted on 12 May 2026
in Occupational Health and Safety
Editorial
Accepted on 12 May 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 May 2026
in Neuroinfectious Diseases
Original Research
Accepted on 12 May 2026
in Geoinformatics
Original Research
Accepted on 12 May 2026
in Neonatology
Mini Review
Accepted on 12 May 2026
in Genitourinary Oncology
Original Research
Accepted on 12 May 2026
in Children and Health
Original Research
Accepted on 12 May 2026
in Sport Psychology